Journal of Clinical Lipidology
Volume 1, Issue 6 , Pages 593-598 , December 2007

Free oxygen radicals in whole blood correlate strongly with high-sensitivity C-reactive protein

  • Matthey T. Harris, MD

      Affiliations

    • Emory University School of Medicine, 1670 Clairmont Road, Mail Code 151, Decatur, GA 30033, USA
    • ,
  • Warren W. Davis, MD

      Affiliations

    • Atlanta VA Medical Center, Atlanta, GA, USA
    • ,
  • Ngoc-Anh Le, PhD

      Affiliations

    • Emory University School of Medicine, 1670 Clairmont Road, Mail Code 151, Decatur, GA 30033, USA
    • Corresponding Author InformationCorresponding author.
    • ,
  • Barry Eggleston, PhD

      Affiliations

    • Rho Incorporated, Chapel Hill, NC, USA
    • ,
  • Garth E. Austin, MD, PhD

      Affiliations

    • Atlanta VA Medical Center, Atlanta, GA, USA
    • ,
  • Mohamad Moussa, MD

      Affiliations

    • Atlanta VA Medical Center, Atlanta, GA, USA
    • ,
  • W. Virgil Brown, MD

      Affiliations

    • Emory University School of Medicine, 1670 Clairmont Road, Mail Code 151, Decatur, GA 30033, USA

Received 10 October 2007 ,Accepted 12 October 2007.

References 

  1. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868–874
  2. Tracy RP. Inflammation in cardiovascular disease. Circulation. 1998;97:2000–2002
  3. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115–126
  4. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease (A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association). Circulation. 2003;107:499–511
  5. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease and detection and prevention. Circulation. 2003;107:363–369
  6. Rattazzi M, Puato M, Faggin E, et al. C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders?. J Hypertens. 2003;21:1787–1803
  7. Griendling KK, Fitzgerald GA. Oxidative stress and cardiovascular injury (part I: basic mechanisms and in vivo monitoring of ROS). Circulation. 2003;108:1912–1916
  8. Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature, molecular and cellular mechanisms. Hypertension. 2003;42:1075–1081
  9. Griendling KK, Fitzgerald GA. Oxidative stress and cardiovascular injury (part II: animal and human studies). Circulation. 2003;108:2034–2040
  10. Wang Z, Castresana MR, Newman WH. Reactive oxygen and NF-κB in VEGF-induced migration of human vascular smooth muscle cells. Biochem Biophys Res Commun. 2001;285:669–674
  11. Volk T, Hensel M, Schuster H, et al. Secretion of MCP-1 and IL-6 by cytokine stimulated production of reactive oxygen species in endothelial cells. Mol Cell Biol. 2000;206:105–112
  12. Alberti A, Bolognini L, Macciantelli D, et al. The radical cation of N,N,-diethyl-para-phenylendiamine: a possible indicator of oxidative stress in biological samples. Res Chem Intermed. 2000;26:253–267
  13. Wilson PWF, D’Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847
  14. Herrington D, Kesler K, Reiber J, et al. Arterial compliance adds to conventional risk factors for prediction of angiographic coronary artery disease. Am Heart J. 2003;146:662–667
  15. Wang TD, Chen WJ, Lin JW, et al. Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles. Atherosclerosis. 2003;170:315–323
  16. Beswick RA, Dorrance AM, Leite R, et al. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension. 2001;38:1107–1111
  17. Rajagopalan S, Kurz S, Munzel T, et al. Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADP/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916–1923
  18. Warnholtz A, Nickenig G, Schulz E, et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis. Circulation. 1999;99:2027–2033
  19. Sato K, Komaru T, Shioiri H, et al. Hypercholesterolemia impairs transduction of vasodilator signals derived from ischemic myocardium. Arterioscler Thromb Vasc Biol. 2004;24:2034–2039
  20. Hink U, Li H, Mollnau H, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 2001;88:e14–e22
  21. Kim YK, Lee MS, Son SM, et al. Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes. Diabetes. 2002;51:522–527
  22. Tomasz JG, Mussa S, Gastaldi D, et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus. Circulation. 2002;105:1656–1662
  23. Folsom AR, Aleksic N, Catellier D, et al. C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2002;144:233–238
  24. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–979
  25. Ridker PM, Buring JE, Cook NR, et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 15,218 initially healthy American women. Circulation. 2003;107:391–397
  26. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and LDL cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557–1565
  27. Koenig W, Sund M, Frolich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984–1992. Circulation. 1999;99:237–242
  28. Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reactive protein to risk of cardiovascular disease in elderly (Results from the Cardiovascular Health Study and the Rural Health Promotion Project). Arterioscler Thromb Vasc Biol. 1997;17:1121–1127
  29. Belcaro G, Carratelli M, Cesarone M, et al. Oxygen free radicals: a method, a product, an application. Int J Angiol. In press.
  30. Iamelle L, Vernocchi A, Amboni P, et al. Normal values of free radicals in newborns and comparison with adults (abstract). Ospedali Riuniti di Bergamo. Clin Pathol Clin Chem Lab (Largo Barozzi). 1:24100.
  31. Abramson JL, Hooper WC, Jones DP, et al. Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary disease. Atherosclerosis. 2005;178:115–121

PII: S1933-2874(07)00290-5

doi: 10.1016/j.jacl.2007.10.008

Journal of Clinical Lipidology
Volume 1, Issue 6 , Pages 593-598 , December 2007

Article Tools

* Image Usage & Resolution